Medscape16h
When to Use Anthracyclines in Early Breast Cancer
Post hoc data from TAILORx show that adding an anthracycline to taxane-based chemotherapy benefits patients with HR-positive ...
Study finds chest wall irradiation may be unnecessary for many breast cancer patients
Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent ...
News Medical on MSN4d
Most patients with intermediate-risk breast cancer may safely avoid chest wall irradiation after mastectomy
Patients with intermediate-risk breast cancer had similar rates of 10-year overall survival whether or not they underwent chest wall irradiation (CWI) after mastectomy, according to results from the ...
EurekAlert!7d
Particle that only has mass when moving in one direction observed for first time
For the first time, scientists have observed a collection of particles, also known as a quasiparticle, that's massless when moving one direction but has mass in the other direction. The quasiparticle, ...
High-risk breast cancer patients see improved outcomes with anthracyclines
Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...
Medpage Today on MSN2d
Mixed Signals From Trials of Perioperative, Neoadjuvant Immunotherapy for Early TNBC
The results, reported at the San Antonio Breast Cancer Symposium (SABCS), added to the history of mixed messages from trials ...
Prime Minister of India5d
PM interacts with participants of Smart India Hackathon 2024
150% increase recorded this year in internal hackathons at institute level, making this the largest edition so far ...